ProMIS Neurosciences Float d'actions
Quel est le Float d'actions de ProMIS Neurosciences?
Le Float d'actions de ProMIS Neurosciences, Inc. est 409.472M 94.84%
Quelle est la définition de Float d'actions ?
Le flottant des actions est la partie des actions d’une société qui est entre les mains d’investisseurs publics, par opposition aux actions immobilisées.
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Float d'actions des entreprises dans Health Care secteur sur OTC par rapport à ProMIS Neurosciences
Que fait ProMIS Neurosciences?
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Entreprises avec float d'actions similaire à ProMIS Neurosciences
- China High Speed Transmission Equipment Co a Float d'actions de 408.823M 25.00%
- Mobecom a Float d'actions de 409.007M 72.31%
- Buru a Float d'actions de 409.279M 76.01%
- Convenience Retail Asia a Float d'actions de 409.283M 52.73%
- RooLife Ltd a Float d'actions de 409.365M 58.90%
- CSMall a Float d'actions de 409.440M 33.08%
- ProMIS Neurosciences a Float d'actions de 409.472M 94.84%
- Waste Management a Float d'actions de 409.566M 96.06%
- IG Plc a Float d'actions de 409.666M 94.92%
- Alderan Resources a Float d'actions de 409.707M 96.27%
- Vikas Multicorp a Float d'actions de 409.801M 61.76%
- Bank of Maharashtra a Float d'actions de 410.227M 6.25%
- Senior Plc a Float d'actions de 410.633M 97.91%